V

V. Gabayan

University of California, Los Angeles

Publishes on Iron Metabolism and Disorders, Erythropoietin and Anemia Treatment, COVID-19 Clinical Research Studies. 5 papers and 471 citations.

5Publications
471Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Suppression of hepcidin during anemia requires erythropoietic activity
Cited by 471Open Access

Hepcidin, the principal iron regulatory hormone, regulates the absorption of iron from the diet and the mobilization of iron from stores. Previous studies indicated that hepcidin is suppressed during anemia, a response that would appropriately increase the absorption of iron and its release from stores. Indeed, in the mouse model, hepcidin-1 was suppressed after phlebotomy or erythropoietin administration but the suppression was reversed by inhibitors of erythropoiesis. The suppression of hepcidin necessary to match iron supply to erythropoietic demand thus requires increased erythropoiesis and is not directly mediated by anemia, tissue hypoxia, or erythropoietin.